Literature DB >> 17888029

Association of microRNA-34a overexpression with proliferation is cell type-dependent.

Khokon Kumar Dutta1, Yi Zhong, Yu-Ting Liu, Takuji Yamada, Shinya Akatsuka, Qian Hu, Minako Yoshihara, Hiroki Ohara, Masanori Takehashi, Takashi Shinohara, Hiroshi Masutani, Janice Onuki, Shinya Toyokuni.   

Abstract

Recently Welch et al. reported that microRNA (miRNA)-34a functions as a potential tumor suppressor in neuroblastoma cells (Oncogene 26: 5017-22, 2007). Here, we conversely show that miRNA-34a supports cell proliferation in rat oxidative stress-induced renal carcinogenesis and is overexpressed in various types of human cancers. While searching for genetically unstable chromosomal areas in rat renal carcinogenesis, we found the miRNA-34 family reciprocally overexpressed in chromosomal areas with frequent allelic loss. By in situ hybridization and reverse transcription-polymerase chain reaction, cerebral neurons and Purkinje cells showed the highest expression of a major type, miRNA-34a, followed by a variety of endocrine cells and proliferating cells including germinal center lymphocytes and mouse embryonic fibroblasts and stem cells. In contrast, normal renal tubules, hepatocytes and myocardial cells showed faint expression. After 3 weeks of ferric nitrilotriacetate (Fe-NTA)-induced oxidative stress, regenerating renal proximal tubular cells showed high miRNA-34a expression. All of the Fe-NTA-induced rat renal carcinomas and an array of human cancers (151 positive cases of 177) showed high expression of miRNA-34a. Furthermore, knockdown of miRNA-34a with small interfering RNA significantly suppressed proliferation not only of renal carcinoma cells but also of HeLa and MCF7 cells. These results indicate that miRNA-34a overexpression, an acquired trait during carcinogenesis, supports cell proliferation in the majority of cancers suggesting an unexpected link in the cellular metabolism between cancer and neuronal and/or endocrine cells, which warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888029     DOI: 10.1111/j.1349-7006.2007.00619.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  47 in total

Review 1.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

2.  Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.

Authors:  Katia Ruggero; Alessandro Guffanti; Alberto Corradin; Varun Kumar Sharma; Gianluca De Bellis; Giorgio Corti; Angela Grassi; Paola Zanovello; Vincenzo Bronte; Vincenzo Ciminale; Donna M D'Agostino
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  Role of miR-34c microRNA in the late steps of spermatogenesis.

Authors:  Frantz Bouhallier; Nathalie Allioli; Fabrice Lavial; Frédéric Chalmel; Marie-Hélène Perrard; Philippe Durand; Jacques Samarut; Bertrand Pain; Jean-Pierre Rouault
Journal:  RNA       Date:  2010-02-11       Impact factor: 4.942

4.  Linoleic acid induces migration and invasion through FFAR4- and PI3K-/Akt-dependent pathway in MDA-MB-231 breast cancer cells.

Authors:  Nathalia Serna-Marquez; Ricardo Diaz-Aragon; Emmanuel Reyes-Uribe; Pedro Cortes-Reynosa; Eduardo Perez Salazar
Journal:  Med Oncol       Date:  2017-04-29       Impact factor: 3.064

5.  Loss of miR-17~92 results in dysregulation of Cftr in nephron progenitors.

Authors:  Yu Leng Phua; Kevin Hong Chen; Shelby L Hemker; April K Marrone; Andrew J Bodnar; Xiaoning Liu; Andrew Clugston; Dennis Kostka; Michael B Butterworth; Jacqueline Ho
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-06

6.  Unveiling of miRNA Expression Patterns in Purkinje Cells During Development.

Authors:  Lukas Pieczora; Lara Stracke; Matthias Vorgerd; Stephan Hahn; Carsten Theiss; Verena Theis
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

7.  miRNA regulation of Sirtuin-1 expression in human astrocytoma.

Authors:  Sara Giovanna Romeo; Alfredo Conti; Francesca Polito; Chiara Tomasello; Valeria Barresi; Domenico La La Torre; Maria Cucinotta; Flavio Filippo Angileri; Marcello Bartolotta; Rosa Maria Di Giorgio; M'Hammed Aguennouz
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

Review 8.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 9.  [MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].

Authors:  A Schaefer; M Jung; G Kristiansen; M Lein; M Schrader; K Miller; A Erbersdobler; C Stephan; K Jung
Journal:  Urologe A       Date:  2009-08       Impact factor: 0.639

10.  Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.

Authors:  Huiqing Liu; Angela R Brannon; Anupama R Reddy; Gabriela Alexe; Michael W Seiler; Alexandra Arreola; Jay H Oza; Ming Yao; David Juan; Louis S Liou; Shridar Ganesan; Arnold J Levine; W K Rathmell; Gyan V Bhanot
Journal:  BMC Syst Biol       Date:  2010-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.